SEARCH

SEARCH BY CITATION

REFERENCES

  • Abbott NJ, Pichon Y. (1987) The glial blood-brain barrier of crustacea and cephalopods: a review. J Physiol 82:304313.
  • Abbott NJ, Khan EU, Rollinson CM, Reichel A, Janigro D, Dombrowski SM, Dobbie MS, Begley DJ. (2002) Drug resistance in epilepsy: the role of the blood-brain barrier. Novartis Found Symp 243:3847.
  • Anderson CM, Baldwin SA, Young JD, Cass CE, Parkinson FE. (1999) Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT-2) in rat brain. Brain Res Mol Brain Res 70:293297.
  • Aronica E, Yankaya B, Troost D, Van Vliet EA, Lopes da Silva FH, Gorter JA. (2001) Induction of neonatal sodium channel II and III alpha-isoform mRNAs in neurons and microglia after status epilepticus in the rat hippocampus. Eur J Neurosci 13:12611266.
  • Aronica E, Gorter JA, Jansen GH, Van Veelen CW, Van Rijen PC, Leenstra S, Ramkema M, Scheffer GL, Scheper RJ, Troost D. (2003) Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118:417429.
  • Ates N, Esen N, Ilbay G. (1999) Absence epilepsy and regional blood-brain barrier permeability: the effects of pentylenetetrazole-induced convulsions. Pharmacol Res 39:305310.
  • Awasthi S, Sharma R, Singhal SS, Zimniak P, Awasthi YC. (2002a) RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metab Dispos 30:13001310.
  • Awasthi S, Sharma R, Yang Y, Singhal SS, Pikula S, Bandorowicz-Pikula J, Singh SV, Zimniak P, Awasthi YC. (2002b) Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76). Acta Biochim Pol 49:855867.
  • Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. (2003a) Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer 106:635646.
  • Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak P, Awasthi YC. (2003b) Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int J Oncol 22:721732.
  • Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, Singhal SS, Awasthi S. (2003c) Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med 24:219230.
  • Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 6:61.
  • Ballabh P, Braun A, Nedergaard M. (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:113.
  • Bartolomei F, Gastaldi M, Massacrier A, Planells R, Nicolas S, Cau P. (1997) Changes in the mRNAs encoding subtypes I, II and III sodium channel alpha subunits following kainate-induced seizures in rat brain. J Neurocytol 26:667678.
  • Bartus RT. (1999) The blood-brain barrier as a target for pharmacological modulations. Curr Opin Drug Discov Develop 2:152167.
  • Baskaya MK, Rao AM, Dogan A, Donaldson D, Dempsey RJ. (1997) The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci Lett 226:3336.
  • Benveniste EN. (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263:C1-C16.
  • Bough KJ, Eagles DA. (1999) A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 40:138143.
  • Bough KJ, Gudi K, Han FT, Rathod AH, Eagles DA. (2002) An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res 50:313325.
  • Brandt C, Volk HA, Loscher W. (2004) Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia 45:14881497.
  • Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. (1998) Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4:11661172.
  • Cass CE, Young JD, Baldwin SA. (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76:761770.
  • Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13:557568.
  • Cornford EM, Hyman S, Swartz BE. (1994) The human brain GLUT1 glucose transporter: ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab 14:106112.
  • Cornford EM, Oldendorf WH. (1986) Epilepsy and the blood-brain barrier. Adv Neurol 44:787812.
  • Cornford EM, Hyman S, Black KL, Cornford ME, Vinters HV, Pardridge WM. (1995) High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. J Neuropathol Exp Neurol. 54:842851.
  • Cornford EM, Hyman S, Cornford ME, Landaw EM, Delgado-Escueta AV. (1998) Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier. J Cereb Blood Flow Metab 18:2642.
  • Cornford EM. (1999) Epilepsy and the blood brain barrier: endothelial cell responses to seizures. Adv Neurol 79:845862.
  • Cucullo L, Aumayr B, Rapp E, Janigro D. (2005) Drug delivery and in vitro models of the blood-brain barrier. Curr Opin Drug Discov Devel 8:8999.
  • Czeisler B, Janigro D. (2006) Reading and writing the Blood Brain Barrier: relevance to Therapeutics. Recent Patents on CNS Drug Discovery 1:157173.
  • Davies A, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD, Baldwin SA. (1977) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3:8993.
  • De Feo MR, Mecarelli O, Ricci G, Rina MF. (1991) Effects of carbamazepine on bicuculline and pentylenetetrazol-induced seizures in developing rats. Brain Dev 13:343347.
  • De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703709.
  • De Vivo DC, Leary L, Wang D. (2002) Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 17(suppl. 3):3S15-3S23.
  • De-Boer AG, Breimer DD. (1998) Cytokines and blood-brain barrier permeability. Prog Brain Res 115P425-51:425451.
  • DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. (1978) Chronic ketosis and cerebral metabolism. Ann Neurol 3:331337.
  • Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143:113.
  • Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, Mayberg MR, Bengez L, Janigro D. (2001) Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42:15011506.
  • Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ. (2005) Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57:152155.
  • Ebert U, Brandt C, Loscher W. (2002) Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat. Epilepsia 43(suppl. 5):8695.
  • Ellerkmann RK, Remy S, Chen J, Sochivko D, Elger CE, Urban BW, Becker A, Beck H. (2003) Molecular and functional changes in voltage-dependent Na(+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells. Neuroscience 119:323333.
  • Engel J Jr., Kuhl DE, Phelps ME. (1982) Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 218:6466.
  • Faaland CA, Race JE, Rickens G, Warner FJ, Williams WJ, Holtzman EJ. (1998) Molecular characterization of two novel transporters from juman and mouse kidney and from LLC-PK1 cells reveals a novel conserved family that is homologous to bacterial and Apergillis nucleobase transporters. Biochem Biophys Acta 1442:353360.
  • Fieschi C, Lenzi GL, Zanette E, Orzi F, Passero S. (1980) Effects on EEG of the osmotic opening of the blood-brain barrier in rats. Life Sci 27:239243.
  • Freyer D, Manz R, Ziegenhorn A, et al. (1999) Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 163:43084314.
  • Fujikawa DG, Shinmei SS, Cai B. (2000) Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 41(suppl. 6):S913.
  • Gilmore RL. (1988) Seizures and antiepileptic drug use in transplant patients. Neurol Clin 6:279296.
  • Golden PL, Pardridge WM. (2000) Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. Cell Mol Neurobiol 20:165181.
  • Golden PL, Pollack GM. (2003) Blood-brain barrier efflux transport. J Pharm Sci 92:17391753.
  • Grant GA, Janigro D. (2004) The blood-brain barrier. In WinnHR, eds. Youmans neurological surgery. Saunders, Philadelphia , pp. 153174.
  • Griffith DA, Jarvis SM. (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153181.
  • Griffiths M, Yao SYM, Abidi F, Phillips SEV, Cass CE, Young JD, Baldwin SA. (1997) Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328:739743.
  • Hallene KL, Oby E, Cucullo L, Marchi N, Janigro D. (2005) Impaired vasculogenesis as a mechanism of central nervous system malformations. Society for Neuroscience, Washington , DC .
  • Henry TR, Sutherling WW, Engel J Jr., Risinger MW, Levesque MF, Mazziotta JC, Phelps ME. (1991) Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 10:174182.
  • Herman ST. (2002) Epilepsy after brain insult: targeting epileptogenesis. Neurology 59:S21-S26.
  • Hogue DL, Ling V. (1999) A human nucleobase transporter-like cDNA (SLC23A1): member of a transporter family conserved from bacteria to mammals. Genomics 59:1823.
  • Hori A, Tandon P, Holmes GL, Stafstrom CE. (1997) Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 38:750758.
  • Huguenard JR. (2002) Block of T -Type Ca(2+) channels is an important action of succinimide antiabsence drugs. Epilepsy Curr 2:4952.
  • Ilbay G, Sahin D, Ates N. (2003) Changes in blood-brain barrier permeability during hot water-induced seizures in rats. Neurol Sci 24:232235.
  • Janigro D. (1999) Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 37:223232.
  • Kanno O. (1987) Electroencephalographic study of 137 patients with thalidomide embryopathy. Jpn J Psychiatr Neurol 41:197205.
  • Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg MR, Janigro D. (2002) Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res 940:102104.
  • Korn A, Golan H, Melamed I, Pascual-Marqui R, Friedman A. (2005) Focal cortical dysfunction and blood-brain barrier disruption in patients with postconcussion syndrome. J Clin Neurophysiol 22:19.
  • Krizanac-Bengez L, Kapural M, Parkinson F, Cucullo L, Hossain M, Mayberg MR, Janigro D. (2003) Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6. Brain Res 977:239246.
  • Krizanac-Bengez L, Mayberg MR, Janigro D. (2004a) The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 26:846853.
  • Krizanac-Bengez L, Mayberg MR, Janigro D. (2004b) The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res. 26:846853.
  • Krizanac-Bengez L, Mayberg MR, Cunningham E, Hossain M, Ponnampalam S, Parkinson F, Janigro D. (2006) Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model. J Cell Physiol 206:6877.
  • Kroll RA, Neuwelt EA. (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42:10831099.
  • Kubova H, Druga R, Lukasiuk K, Suchomelova L, Haugvicova R, Jirmanova I, Pitkanen A. (2001) Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 21:35933599.
  • Kwan P, Sills GJ, Butler E, Gant TW, Meldrum BS, Brodie MJ. (2002) Regional expression of multidrug resistance genes in genetically epilepsy-prone rat brain after a single audiogenic seizure. Epilepsia 43:13181323.
  • Laflamme N, Lacroix S, Rivest S. (1999) An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during entotoxemia. J Neurosci 19:1092310930.
  • Lazarowski A, Ramos AJ, Garcia-Rivello H, Brusco A, Girardi E. (2004) Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model. Cell Mol Neurobiol 24:7785.
  • Leschinger A, Stabel J, Igelmund P, Heinemann U. (1993) Pharmacological and electrographic properties of epileptiform activity induced by elevated K+ and lowered Ca2+ and Mg2+ concentration in rat hippocampal slices. Exp Brain Res 96:230240.
  • Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OCIII, Burnham WM. (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 54:219226.
  • Loscher W. (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23:113118.
  • Loscher W, Potschka H. (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:8698.
  • Lu Y, Yan Y, Wang XF. (2004) Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains. Chin Med J (Engl) 117:16821686.
  • Marchi N, Hallene KL, Kight KM, Cucullo L, Moddel G, Bingaman W, Dini G, Vezzani A, Janigro D. (2004) Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. BMC Med 2:37.
  • Marchi N, Bassanini S, Rizzi M, Guiso G, Caccia S, Gagliardi B, Battaglia G, Vezzani A. (2005) Mechanisms of drug-resistance in an experimental model of cortical malformation: effects of neuronal dysplasia, seizures and their combination. Epilepsia 46(suppl. 6):62.
  • Marroni M, Marchi N, Cucullo L, Abbott NJ, Signorelli K, Janigro D. (2003) Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. Curr Drug Targets 4:297304.
  • Morris AA. (2005) Cerebral ketone body metabolism. J Inherit Metab Dis 28:109121.
  • Muller-Schwarze AB, Tandon P, Liu Z, Yang Y, Holmes GL, Stafstrom CE. (1999) Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10:15171522.
  • Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP. (1983) Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. AJR Am J Roentgenol 141:829835.
  • Neuwelt EA, Howieson J, Frenkel EP, Specht HD, Weigel R, Buchan CG, Hill SA. (1986) Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 19:573582.
  • Nitsch C, Klatzo I. (1983) Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. J Neurol Sci 59:305322.
  • Oby E, Caccia S, Vezzani A, Moeddel G, Hallene K, Guiso G, Said T, Bingaman W, Marchi N, Baumgartner C, Pirker R, Cz'eh T, Lo Russo G, Janigro D. (2006) In vitro responsiveness of human drug resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance. Brain Res 1186:201213.
  • Oprica M, Eriksson C, Schultzberg M. (2003) Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. J Cell Mol Med 7:127140.
  • Oztas B, Turkel N. (2001) Influence of an abrupt increase in blood pressure on the blood-brain barrier permeability during acute hypertension and epileptic seizures. Pharmacol Res 44:209212.
  • Pappius HM, Savaki HE, Fieschi C, Rapoport SI, Sokoloff L. (1979) Osmotic opening of the blood-brain barrier and local cerebral glucose utilization. Ann Neurol 5:211219.
  • Pardridge WM. (1999) Blood-brain barrier biology and methodology. J Neurovirol 5:556569.
  • Patchell RA. (1994) Neurological complications of organ transplantation. Ann Neurol 36:688703.
  • Paul DL. (1995) New functions for gap junctions. Curr Opin Cell Biol;7:665672.
  • Pavlovsky L, Seiffert E, Heinemann U, Korn A, Golan H, Friedman A. (2005) Persistent BBB disruption may underlie alpha interferon-induced seizures. J Neurol 252:4246.
  • Pont F, Collet A, Lallement G. (1995) Early and transient increase of rat hippocampal blood-brain barrier permeability to amino acids during kainic acid-induced seizures. Neurosci Lett 184:5254.
  • Potschka H, Fedrowitz M, Loscher W. (2002) P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 327:173176.
  • Puig B, Ferrer I. (2002) Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat. Neurosci Lett 321:182186.
  • Ragozzino D, Palma E, Di Angelantonio S, Amici M, Mascia A, Arcella A, Giangaspero F, Cantore G, Di Gennaro G, Manfredi M, Esposito V, Quarato PP, Miledi R, Eusebi F. (2005) Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc Natl Acad Sci U S A 102:1521915223.
  • Rapoport SI. (2000) Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 20:217230.
  • Remy S, Urban BW, Elger CE, Beck H. (2003) Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats. Eur J Neurosci 17:26482658.
  • Remy S, Beck H. (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129:1835.
  • Rho JM, Kim DW, Robbins CA, Anderson GD, Schwartzkroin PA. (1999) Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res 37:233240.
  • Rho JM, Robbins CA, Wenzel J, Tempel BL, Schwartzkroin PA. (2005) An experimental ketogenic diet promotes long-term survival and reduces synaptic reorganization in the hippocampus of epileptic Kv1.1 null mutant mice. Epilepsia 41(suppl. 7):34.
  • Rivest S. (1999) What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies. Mol Psychiatr 4:500507.
  • Rizzi M, Caccia S, Guiso G, Richichi C, Gorter JA, Aronica E, Aliprandi M, Bagnati R, Fanelli R, D'Incalci M, Samanin R, Vezzani A. (2002) Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J Neurosci 22:58335839.
  • Roman-Goldstein S, Clunie DA, Stevens J, Hogan R, Monard J, Ramsey F, Neuwelt EA. (1994) Osmotic blood-brain barrier disruption: CT and radionuclide imaging. AJNR Am J Neuroradiol 15:581590.
  • Sadzot B, Debets RM, Maquet P, Van Veelen CW, Salmon E, Van Emde BW, Velis DN, Van Huffelen AC, Franck G. (1992) Regional brain glucose metabolism in patients with complex partial seizures investigated by intracranial EEG. Epilepsy Res 12:121129.
  • Salazar AM, Jabbari B, Vance SC, Grafman J, Amin D, Dillon JD. (1985) Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 35:14061414.
  • Schilling L and Wahl M. (1999) Mediators of cerebral edema. Adv Exp Med Biol 474:123141.
  • Schinkel AH, Wagenaar E, Van Deemter L, Mol CA, Borst P. (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:16981705.
  • Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24:78297836.
  • Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM. (2000) In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. J Neurosurg 92:599605.
  • Silverman A, Sutherland A, Wilhelm M, Silver R. (2000) Mast Cells migrate from blood to brain. J Neurosci 20:401408.
  • Sinclair CJ, LaRiviere CG, Young JD, Cass CE, Baldwin SA, Parkinson FE. (2000a) Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions. J Neurochem 75:15281538.
  • Sinclair CJ, Shepel PN, Geiger JD, Parkinson FE. (2000b) Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation. Biochem Pharmacol 59:477483.
  • Sisodiya SM, Lin WR, Squier MV, Thom M. (2001) Multidrug-resistance protein 1 in focal cortical dysplasia. Lancet 357:4243.
  • Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M. (2002a) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:2231.
  • Sisodiya SM, Lint WR, Harding BN, Squier MV, Thom M. (2002b) Drug resistance in epilepsy: human epilepsy. Novartis Found Symp 243:167174.
  • Sloviter RS. (1999) Status epilepticus-induced neuronal injury and network reorganization. Epilepsia 40(suppl. 1):S34S39.
  • Stephenson JB. (1976) Epilepsy: a neurological complication of thalidomide embryopathy. Dev Med Child Neurol 18:189197.
  • Su H, Sochivko D, Becker A, Chen J, Jiang Y, Yaari Y, Beck H. (2002) Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci 22:36453655.
  • Su SW, Cilio MR, Sogawa Y, Silveira DC, Holmes GL, Stafstrom CE. (2000) Timing of ketogenic diet initiation in an experimental epilepsy model. Brain Res Dev Brain Res 125:131138.
  • Suzuki R, Nitsch C, Fujiwara K, Klatzo I. (1984) Regional changes in cerebral blood flow and blood-brain barrier permeability during epileptiform seizures and in acute hypertension in rabbits. J Cereb Blood Flow Metab 4:96102.
  • Sztriha L, Joo F, Szerdahelyi P, Eck E, Koltai M. (1986) Effects of dexamethasone on brain edema induced by kainic acid seizures. Neuroscience 17:107114.
  • Thomas WE. (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 17:6174.
  • Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C. (1995a) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:16.
  • Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C. (1995b) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:16.
  • Tomkins O, Kaufer D, Korn A, Shelef I, Golan H, Reichenthal E, Soreq H, Friedman A. (2001) Frequent blood-brain barrier disruption in the human cerebral cortex. Cell Mol Neurobiol 21:675691.
  • Van Vliet EA, Aronica E, Redeker S, Gorter JA. (2004) Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy. Epilepsia 45:15061516.
  • Van Vliet EA, Redeker S, Aronica E, Edelbroek PM, Gorter JA. (2005a) Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia 46:15691580.
  • Van Vliet EA, Redeker S, Aronica E, Edelbroek PM, Gorter JA. (2005b) Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia 46:15691580.
  • Vaughn BV, Ali II, Olivier KN, Lackner RP, Robertson KR, Messenheimer JA, Paradowski LJ, Egan TM. (1996) Seizures in lung transplant recipients. Epilepsia 37:11751179.
  • Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C, De Simoni MG. (2002) Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43(suppl. 5):3035.
  • Vezzani A. (2004) Brain inflammation and seizures. Epilepsy Curr 4:7375.
  • Vezzani A. (2005) Inflammation and epilepsy. Epilepsy Curr. 5:16.
  • Vezzani A, Granata T. (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:17241743.
  • Volk HA, Burkhardt K, Potschka H, Chen J, Becker A, Loscher W. (2004) Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience 123:751759.
  • Volk HA, Loscher W. (2005) Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128:13581368.
  • Washington CB, Giacomini KM. (1995) Mechanisms of nucleobase transport in rabbit choroid plexus. Evidence for a Na(+)-dependent nucleobase transporter with broad substrate selectivity. J Biol Chem 270:2281622819.
  • Whitaker WR, Faull RL, Dragunow M, Mee EW, Emson PC, Clare JJ. (2001) Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience 106:275285.
  • Withrow CD. (1980) The ketogenic diet: mechanism of anticonvulsant action. Adv Neurol 27:635642.
  • Xiong ZQ, Qian W, Suzuki K, McNamara JO. (2003) Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 23:955960.
  • Yao SYM, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, Young AR. (1997) Molecular cloning and functional characterization of nitrobenzylthionosine (NBMPR)-sensitive(es) and NBMPR-insensitive(ei) equilibrative transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272:2842328430.
  • Zappulla RA, Spigelman MK, Omsberg E, Rosen JJ, Malis LI, Holland JF. (1985a) Electroencephalographic consequences of sodium dehydrocholate-induced blood-brain barrier disruption: Part 1. Acute and chronic effects of intracarotid sodium dehydrocholate. Neurosurgery 16:630638.
  • Zappulla RA, Spigelman MK, Rosen JJ, Marotta D, Malis LI, Holland JF. (1985b) Electroencephalographic consequences of sodium dehydrocholate-induced blood-brain barrier disruption: Part 2. Generation and propagation of spike activity after the topical application of sodium dehydrocholate. Neurosurgery 16:639643.
  • Zhang L, Ong WY, Lee T. (1999) Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections. Exp Brain Res 126:509516.